Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19620634 | 0.91 | MDM2 (0.35) | KDM4EPOLBMAPTMDM2RAB9A | |
| SCHEMBL19620609 | 0.90 | MDM2 (0.38) | KDM4EPOLBMAPTMDM2RAB9A | |
| SCHEMBL19620490 | 0.88 | ADK (0.38) | KDM4EPOLBMAPTRAB9ADAO | |
| SCHEMBL19620605 | 0.88 | CNR1 (0.35) | KDM4EPOLBMAPTMDM2RAB9A | |
| SCHEMBL19620522 | 0.86 | KDM4E (0.42) | KDM4EPOLBMAPTMDM2RAB9A | |
| SCHEMBL19620505 | 0.85 | LMNA (0.37) | KDM4EPOLBMAPTDAOMEN1 | |
| SCHEMBL19620660 | 0.85 | PSEN1 (0.35) | KDM4EPOLBMAPT | |
| SCHEMBL19620638 | 0.84 | ADORA2A (0.32) | KDM4EPOLBMAPTDAO | |
| SCHEMBL19620642 | 0.83 | ADK (0.38) | KDM4EPOLBMAPTTOP2ADAO | |
| SCHEMBL19620342 | 0.83 | MDM2 (0.36) | KDM4EPOLBMAPTMDM2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3345596-B1 | INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER | RHODE ISLAND HOSPITAL (US) | 2021-01-20 | — | — | EP | disclosed |
| EP-2897607-B1 | INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER | RHODE ISLAND HOSPITAL (US) | 2017-11-22 | — | — | EP | disclosed |